Ryan Specialty Holdings (RYAN) is back in focus after Cooper Investors highlighted the stock as a key detractor in its first quarter 2026 letter, citing a softening insurance pricing cycle and weaker sentiment.

The share price has been under pressure for much of 2026, with a year-to-date share price return of negative 34.74% and a 1-year total shareholder return of negative 51.46%. This is despite a recent 7-day share price rebound of 9.12% that followed investor concern around the weakening insurance pricing cycle.

If this shift in sentiment has you thinking more broadly about opportunities, it could be a useful moment to scan for other insurance and financial services businesses via a curated list like 20 top founder-led companies

So with Ryan Specialty’s shares down sharply over the past year but trading at a reported discount to analyst targets and intrinsic estimates, are you looking at an undervalued insurance specialist, or a stock where the market already prices in future growth?

Most Popular Narrative: 40.2% Undervalued

On the latest narrative, Ryan Specialty’s fair value of $55.25 sits well above the recent $33.03 close. This pushes the focus squarely onto the growth and margin story behind that gap.

The updated analyst price target for Ryan Specialty Holdings edges up to $55.25 from $54.88, as analysts weigh softer revenue growth assumptions against slightly higher margin expectations and a modestly lower future P/E. They are also factoring in recent sector wide target cuts tied to AI disruption concerns and excess and surplus market deceleration.

Want to see what kind of earnings trajectory and margin profile are being baked into that fair value? The key moving parts involve revenue growth assumptions, a step change in profitability, and a future P/E that needs to sit well above today’s insurance sector average.

Result: Fair Value of $55.25 (UNDERVALUED)

However, investors still need to weigh softer property insurance pricing and higher spending on new platforms, which could pressure organic growth and delay the margin story.

Another View: Multiples Paint a Tougher Picture

While our fair value model suggests Ryan Specialty Holdings is trading well below intrinsic value, the P/E tells a more demanding story. At 39.3x earnings, the stock sits well above peers at 26.9x and the US Insurance industry at 11.3x, and even above a fair ratio of 27.5x that the market could move toward. This leaves less room for error if growth or margins disappoint.

Next Steps

With the sentiment clearly mixed, this is a good moment to move quickly, review the full picture yourself, and weigh up the 3 key rewards and 2 important warning signs.

Looking for more investment ideas?

If this spotlight on Ryan Specialty has sharpened your thinking, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.

• Target resilient potential by scanning companies with healthy finances using the solid balance sheet and fundamentals stocks screener (46 results).
• Hunt for mispriced opportunities that combine quality and value through the 51 high quality undervalued stocks.
• Strengthen your income focus by reviewing dependable payers in the 10 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.